• $989,928.00
    Market Cap
  • 20.00%
    1-Year Change
  • Specialty Chemicals
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 31
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0005
$0.0007
$0.0006
1-Year Range
$0.0003
$0.002
$0.0006
Latest Close$0.0006
Change
$0.00 (0.00%)
Volume6,535,653
Market Cap$989,928.00
Shares Outstanding1.6B
P/E (TTM)-0.08
Diluted EPS (TTM)-$0.007
Enterprise Value$1.2M

Information as of 08/21/2026

Company Profile

PREMIER BIOMEDICAL INC
https://www.premierbiomedical.com
$989,928.00
Market Cap
-$374,470.00
Net Income
Sector: Basic Materials
Industry: Specialty Chemicals
PO Box 25, Jackson Center, PA, United States, 16133
724 633 7033

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.

Key Executives

  • David Caplan
  • Carl Eller
  • Gustavo Carreño

Current Ownership Distribution

  • Other1.3B (97.96%)
  • Insiders26.5M (2.04%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)